MicroRNA-377-3p released by mesenchymal stem cell exosomes ameliorates lipopolysaccharide-induced acute lung injury by targeting RPTOR to induce autophagy.
Xuxia WeiXiaomeng YiHaijin LvXin SuiPinglan LuLijuan LiYuling AnYang YangHuimin YiGuihua ChenPublished in: Cell death & disease (2020)
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are the severe lung damage and respiratory failure without effective therapy. However, there was a lack of understanding of the mechanism by which exosomes regulate autophagy during ALI/ARDS. Here, we found lipopolysaccharide (LPS) significantly increased inflammatory factors, administration of exosomes released by human umbilical cord mesenchymal stem cells (hucMSCs) successfully improved lung morphometry. Further studies showed that miR-377-3p in the exosomes played a pivotal role in regulating autophagy, leading to protect LPS induced ALI. Compared to exosomes released by human fetal lung fibroblast cells (HFL-1), hucMSCs-exosomes overexpressing miR-377-3p more effectively suppressed the bronchoalveolar lavage (BALF) and inflammatory factors and induced autophagy, causing recoveration of ALI. Administration of miR-377-3p expressing hucMSCs-exosomes or its target regulatory-associated protein of mTOR (RPTOR) knockdown significantly reduced ALI. In summary, miR-377-3p released by hucMSCs-exosomes ameliorated Lipopolysaccharide-induced acute lung injury by targeting RPTOR to induce autophagy in vivo and in vitro.
Keyphrases
- mesenchymal stem cells
- lipopolysaccharide induced
- inflammatory response
- umbilical cord
- lps induced
- acute respiratory distress syndrome
- oxidative stress
- extracorporeal membrane oxygenation
- cell death
- endoplasmic reticulum stress
- bone marrow
- mechanical ventilation
- cell therapy
- signaling pathway
- toll like receptor
- induced apoptosis
- respiratory failure
- stem cells
- endothelial cells
- diabetic rats
- cell cycle arrest
- immune response
- early onset
- high glucose
- transcription factor
- mouse model
- cell proliferation
- replacement therapy
- induced pluripotent stem cells